Mercado Europeu de Vetores Lentivirais – Tendências da Indústria e Previsão para 2028

Personalize o seu relatório Personalize o seu relatório Comprar agora Comprar agora Relatório de amostra grátis Relatório de amostra grátis
Casa Healthcare Europe Lentiviral Vector Market
Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado Europeu de Vetores Lentivirais – Tendências da Indústria e Previsão para 2028

  • Healthcare
  • Publish Reports
  • Jun 2021
  • Europe
  • 350 Páginas
  • Número de tabelas: 197
  • Número de figuras: 52
Comprar agora Comprar agora

>Mercado europeu de vetores lentivirais, por componente (promotor lentiviral, etiquetas de fusão lentivirais, sistemas de embalagem de lentivírus e outros), tipo (produtos e serviços), geração (4ª geração, 3ª geração, 2ª geração e 1ª geração), fluxo de trabalho ( Processamento upstream e processamento downstream), método de entrega (in vivo e ex vivo), indicação de doenças (cancro, doenças genéticas, doenças infeciosas, doenças veterinárias e outras), aplicação (terapia genética e vacinologia), utilizador final (empresas de biotecnologia, empresas farmacêuticas , Organizações de investigação contratual, Organização de desenvolvimento e fabrico de contratos (CDMO) e Institutos académicos/de investigação), País (Alemanha, França, Espanha, Itália, Holanda, Suíça, Rússia, Turquia, Resto da Europa ) Tendências da indústria e previsão para 2028

Mercado Europeu de Vetores Lentivirais

Análise e insights de mercado : Mercado de vetores lentivirais da Europa

Espera-se que o mercado europeu de vetores lentivirais ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 16,9% no período de previsão de 2021 a 2028 e deverá atingir os 322,41 milhões de dólares até 2028. Os biólogos moleculares utilizam frequentemente vectores virais para entregar material genético às células. Este procedimento pode ser realizado in vivo (dentro de um organismo vivo) ou em cultura celular (in vitro). Os vírus desenvolveram mecanismos moleculares especializados para transportar os seus genomas de forma eficiente dentro das células que infetam. Crescente procura de vectores lentivirais e aumento de doenças infecciosas; são os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.

Os vetores lentivirais (LV) são veículos eficientes para a transferência de genes em células de mamíferos devido à sua capacidade de expressar de forma estável um gene de interesse em células que não se dividem e que se dividem. Os lentivírus são agentes patogénicos humanos e animais conhecidos por terem longos períodos de incubação e infeção persistente. O tempo entre a infecção inicial e o aparecimento dos primeiros sintomas pode chegar a vários meses ou anos. Os biólogos moleculares utilizam frequentemente vetores virais para entregar material genético às células. O procedimento pode ser realizado in vivo (dentro de um organismo vivo) ou em cultura celular (in vitro). Os vírus desenvolveram mecanismos moleculares especializados para transportar os seus genomas de forma eficiente dentro das células que infetam. A transdução é a entrega de genes ou outro material genético por um vetor e as células infetadas são referidas como transduzidas. Os vetores lentivírus são também utilizados na terapia genética e no desenvolvimento de vacinas, bem como na investigação em biologia molecular. São obtidos diversos produtos e serviços pelos principais players do mercado para a produção do vetor lentiviral.

A crescente população geriátrica e a procura por desenvolvimentos de vacinas durante o aparecimento do Covid-19 ajudam eficazmente o crescimento do mercado de vetores lentivirais. No entanto, a falta de escalabilidade e as limitações da purificação a jusante de vetores lentivirais podem dificultar o crescimento futuro de um mercado de vetores lentivirais. As iniciativas estratégicas dos principais players do mercado e o aumento do financiamento para a genómica funcionam como uma oportunidade para o crescimento do mercado europeu de vetores lentivirais. As rigorosas políticas regulamentares e os efeitos secundários associados aos produtos de vetores lentivirais funcionam como um desafio para o crescimento futuro do mercado.

O relatório do mercado de vetores lentivirais da Europa fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos , expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado contacte-nos para um resumo do analista, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.

Mercado Europeu de Vetores Lentivirais

Âmbito do mercado de vetores lentivirais da Europa e dimensão do mercado

O mercado europeu de vetores lentivirais está segmentado em oito segmentos notáveis ​​com base no componente, tipo, geração, fluxo de trabalho, método de administração, indicação de doença, aplicação e utilizador final. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.

  • Com base no componente, o mercado europeu de vetores lentivirais está segmentado em promotor lentiviral, etiquetas de fusão lentivirais e sistemas de embalagem de lentivírus e outros. Em 2021, prevê-se que o segmento dos sistemas de embalagem de lentivírus domine o mercado dos vetores lentivirais devido aos crescentes avanços tecnológicos.
  • Com base no tipo, o mercado europeu de vetores lentivirais está segmentado em produtos e serviços. Em 2021, prevê-se que o segmento de produtos domine o mercado dos vetores lentivirais devido ao aumento dos investimentos em terapia genética por parte do governo europeu.
  • Com base na geração, o mercado europeu de vetores lentivirais está segmentado em 4ª geração, 3ª geração, 2ª geração e 1ª geração. Em 2021, prevê-se que o segmento de 4ª geração domine o mercado dos vetores lentivirais devido à sua reduzida mutagénese e efeitos secundários associados.
  • Com base no fluxo de trabalho, o mercado europeu de vetores lentivirais está segmentado em processamento upstream e processamento downstream. Em 2021, prevê-se que o segmento de processamento upstream domine o mercado dos vetores lentivirais devido ao aumento das organizações de investigação e atividades em terapia genética.
  • Com base no método de entrega, o mercado europeu de vetores lentivirais está segmentado em in vivo e ex vivo. Em 2021, prevê-se que o segmento in vivo domine o mercado dos vetores lentivirais devido à aceleração das suas contribuições na investigação e produção de vacinas.
  • On the basis of disease indication, the Europe lentiviral vector market is segmented into cancer, genetic disorders, infectious diseases, veterinary disease and other. In 2021, cancer segment is expected to dominate the lentiviral vector market owing to the rising incidence of cancer cases in various regions of Europe.
  • On the basis of application, the Europe lentiviral vector market is segmented into gene therapy and vaccinology. In 2021, gene therapy segment is expected to dominate the lentiviral vector market due to broad range of its application and permanent cure provided for chronic diseases.
  • On the basis of end user, the Europe lentiviral vector market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations, contract development and manufacturing organization (CDMO) and academic/ research institutes. In 2021, academic/ research institutes segment is expected to dominate the lentiviral vector market due to increasing number of new research institutes launches for R & D applications.

Europe Lentiviral Vector Market Country Level Analysis

The Europe lentiviral vector market is analysed and market size information is provided by component, type, generation, workflow, delivery method, disease indication, application and end user.

The countries covered in the Europe lentiviral vector market report are the U.K, Germany, France, Italy, Spain, Russia, Turkey, Netherlands, Switzerland and rest of Europe.    

Germany is the fastest growing and hence, the dominating country in the Europe region due to rising pharmaceutical industries initiatives for the lentiviral vector.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Increasing Strategic Initiatives by Key Market Players for Lentiviral Vector Production is Creating New Opportunities in the Lentiviral Vector Market    

Europe Lentiviral Vector market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Europe Lentiviral Vector Market Share Analysis

O panorama competitivo do mercado europeu de vetores lentivirais fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura do produto e respiração, domínio da aplicação, curva da linha de vida da tecnologia. Os dados fornecidos acima estão apenas relacionados com o foco da empresa relacionado com o mercado de vetores lentivirais.

As principais empresas que negoceiam no mercado europeu de vetores lentivirais são a Applied Biological Materials Inc., Creative Biolabs, bluebird bio, Inc., System Biosciences, LLC, Cobra Biologics Limited, FUJIFILM Diosynth Biotechnologies (uma subsidiária da FUJIFILM Holdings Corporation), Sirion - Biotech GmbH, Merck KGaA, FinVector Oy, Oxford Biomedica, OriGene Technologies, Inc., Sino Biological Inc., Batavia Biosciences BV, Lonza, Takara Bio Inc., Thermo Fisher Scientific Inc. e Cytiva (uma subsidiária da Danaher) entre outras.

Muitos contratos e acordos são também iniciados pelas empresas de todo o mundo que estão também a acelerar o mercado dos vetores lentivirais.

Por exemplo,

  • Em setembro de 2020, a Waisman Biomanufacturing estabeleceu uma parceria estratégica com a empresa de biotecnologia GigaGen, com sede na Califórnia, a fim de desenvolver um novo medicamento para tratar e prevenir a COVID-19. Esta parceria estratégica feita pela empresa aumentará a utilização de desenvolvimento e testes de novos tipos de medicamentos pela Waisman Biomanufacturing levando a uma maior notoriedade dos seus serviços no mercado.
  • Em abril de 2021, a Oxford Biomedica assina um novo acordo de desenvolvimento e fornecimento de três anos com a Boehringer Ingelheim para o fabrico e fornecimento de vetores virais. A previsão é que este acordo antecipou potenciar o crescimento das vendas da empresa nos próximos anos.

A colaboração, o lançamento de produtos, a expansão de negócios, a atribuição de prémios e reconhecimento, as joint ventures e outras estratégias do player de mercado estão a melhorar a pegada da empresa no mercado de vetores lentivirais, o que também proporciona o benefício para o crescimento do lucro da organização.

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Sample Image Click on image to enlarge
  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE lentiviral vector market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. component LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET application COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insiGHTS
    1. Adherent and Suspension cultures: OVERVIEW
    2. Pricing of Lentiviral Vectors: Product and Service
      1. Product
      2. Services
  5. Europe lentiviral vector market: regulatORY FRAMEWORK
    1. REGULATION IN THE UNITED STATES
    2. REGULATIONS IN EUROPE
    3. REGULATIONS IN INDIA
    4. REGULATIONS IN JAPAN
  6. Market Overview
    1. drivers
      1. RisE IN demand for viral vectors
      2. Emergence of COVID-19 and demand for vaccine development
      3. Benefits of Viral vectors for gene therapy
      4. RISE IN NUMBER OF INFECTIOUS DISEASES
      5. GROWING GERIATRIC POPULATION
    2. Restraints
      1. lack of scalability
      2. Limitations of downstream purification
      3. SHORTAGE OF SKILLED PERSONNELS
    3. OPPORTUNITIES
      1. Increased healthcare facility and funding for genomics
      2. RISE IN technological advancement
      3. IncreasE IN demand FOR personalized medicines
      4. Strategic Initiatives by Key market players
    4. CHALLENGEs
      1. stringent government approval policies
      2. Side-effects associated with lentiviral vectors integration
  7. IMPACT OF COVID-19 ON THE Europe Lentiviral vector Market
    1. impact on price
    2. impact on demand
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS of Government and MANUFACTURERS
    5. CONCLUSION
  8. Europe lentiviral vecTor market, By COMPONENT
    1. overview
    2. lentivirus packaging systems
    3. lentiviral promoter
      1. lentivirus promoter vectors
      2. lentivirus pROMOTERLESS VECTORS
    4. lentiviral fusion tags
    5. otherS
  9. Europe lentiviral vector market, By type
    1. overview
    2. product
      1. Human immunodeficiency virus (hiv)
      2. FELINE immunodeficiency virus (Fiv)
      3. EQUINE INFECTIOUS ANEMIA virus (eiav)
    3. services
  10. Europe lentiviral vector market, By GENERATION
    1. overview
    2. 4th generation
    3. 3rd generation
    4. 2nd generation
    5. 1st generation
  11. Europe lentiviral vector market, By workflow
    1. overview
    2. upstream processing
      1. vector amplification & expansion
      2. vector recovery/ harvesting
    3. downstream processing
      1. purification
      2. fill-finish
  12. Europe lentiviral vector market, By delivery method
    1. overview
    2. in-vivo
    3. ex-vivo
  13. Europe lentiviral vector market, By disease indication
    1. overview
    2. cancer
    3. genetic disorders
      1. b-thalessemia
      2. x-linked adreno leukodystrophy
      3. metachromatic leukodystrophy
      4. wiskott-aldrich syndrome
      5. others
    4. infectious diseases
      1. HIV
      2. OTHERS
    5. veterinary diseases
    6. others
  14. Europe lentiviral vector market, By application
    1. overview
    2. gene therapy
      1. recombinant protein expression
      2. functional assays
      3. in vitro transcription
      4. protein characterization
      5. others
    3. vaccinology
  15. Europe lentiviral vector market, By end user
    1. overview
    2. academic/ research institutes
    3. pharmaceutical companies
    4. contract development and manufacturing organizations
    5. biotechnology companies
    6. contract research organizations
  16. EUROPE Lentiviral Vector MARKET, by REGION
    1. EUROPE
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Netherlands
      7. Switzerland
      8. Russia
      9. Turkey
      10. Rest of Europe
  17. Europe Lentiviral Vector Market: COMPANY landscape
    1. company share analysis: Europe
  18. swot
  19. company profile
    1. Oxford Biomedica
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. Thermo Fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Merck KGaA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. LONZA
      1. COMPANY SNAPSHOT
      2. RECENT ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Cytiva (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. Applied Biological Materials Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. Batavia Biosciences B.V.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. bluebird bio, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. CELL BIOLABS, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. Creative Biolabs
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    11. COBRA BIOLOGICS LIMITED
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. FinVector Oy
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    13. FUJIFIM DIOSYNTH BIOTECHNOLOGIES (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
      1. COMPANY SNAPSHOT
      2. RECENT ANALYSIS
      3. SERVICE PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. GENEMEDI
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. ORIGENE TECHNOLOGIES, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. SINO BIOLOGICAL, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    17. SIRION-Biotech GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. SYSTEM BIOSCIENCES, LLC
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    19. TAKARA BIO INC.
      1. COMPANY SNAPSHOT
      2. RECENT ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    20. Waisman Biomanufacturing
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  20. questionnaire
  21. related reports

Lista de Tabela

TABLE 1 Thermo Fisher Scientific

TABLE 2 The Regents of the University of Michigan

TABLE 3 Kerafast

TABLE 4 Applied Biological Materials Inc.

TABLE 5 Europe lentiviral vector market, By component, 2019-2028 (USD million)

TABLE 6 Europe lentiviRUS PACKAGING SYSTEMS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 7 Europe lentiviRal promoter IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 8 Europe lentiviral promoter in Lentiviral vector Market, By component, 2019-2028 (USD million)

TABLE 9 Europe lentiviRal FUSION TAGS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 10 Europe OTHERS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 11 Europe lentiviral vector market, By TYPE, 2019-2028 (USD million)

TABLE 12 Europe PRODUCT IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 13 Europe product in lentiviral vector market, By TYPE, 2019-2028 (USD million)

TABLE 14 Europe SERVICES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 15 Europe lentiviral vector market, By generation, 2019-2028 (USD million)

TABLE 16 Europe 4TH-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 17 Europe 3RD-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 18 Europe 2ND-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 19 Europe 1ST-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 20 Europe lentiviral vector market, By work flow, 2019-2028 (USD million)

TABLE 21 Europe UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 22 Europe upstream processing in Lentiviral vector Market, By method, 2019-2028 (USD million)

TABLE 23 Europe DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 24 Europe downstream processing in Lentiviral vector Market, By method, 2019-2028 (USD million)

TABLE 25 Europe lentiviral vector market, By delivery method, 2019-2028 (USD million)

TABLE 26 Europe IN-VIVO IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 27 Europe EX-VIVO IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 28 Europe lentiviral vector market, By disease indication, 2019-2028 (USD million)

TABLE 29 Europe CANCER IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 30 Europe GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 31 Europe genetic disorders in Lentiviral vector Market, By disease, 2019-2028 (USD million)

TABLE 32 Europe INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 33 Europe infectious diseases in Lentiviral vector Market, By disease, 2019-2028 (USD million)

TABLE 34 Europe VETERINARY DISEASES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 35 Europe others IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 36 Europe lentiviral vector market, By application, 2019-2028 (USD million)

TABLE 37 Europe GENE THERAPY IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 38 Europe gene therapy in Lentiviral vector Market, By application, 2019-2028 (USD million)

TABLE 39 Europe VACCINOLOGY IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 40 Europe lentiviral vector market, By end user, 2019-2028 (USD million)

TABLE 41 Europe ACADEMIC/ RESEARCH INSTITUTES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 42 Europe pharmaceutical companies IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 43 Europe CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 44 Europe BIOTECHNOLOGY COMPANIES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 45 Europe CONTRACT RESEARCH ORGANIZATIONS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 46 EUROPE Lentiviral Vector Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 47 Europe Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 48 Europe Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 49 Europe Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 50 Europe Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 51 Europe Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 52 Europe Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 53 Europe Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 54 Europe Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 55 Europe Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 56 Europe Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 57 Europe Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 58 Europe Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 59 Europe Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 60 Europe Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 61 Europe Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 62 U.K. Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 63 U.K. Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 64 U.K. Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 65 U.K. Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 66 U.K. Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 67 U.K. Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 68 U.K. Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 69 U.K. Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 70 U.K. Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 71 U.K. Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 72 U.K. Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 73 U.K. Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 74 U.K. Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 75 U.K. Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 76 U.K. Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 77 Germany Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 78 Germany Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 79 Germany Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 80 Germany Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 81 Germany Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 82 Germany Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 83 Germany Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 84 Germany Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 85 Germany Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 86 Germany Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 87 Germany Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 88 Germany Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 89 Germany Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 90 Germany Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 91 Germany Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 92 France Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 93 France Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 94 France Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 95 France Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 96 France Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 97 France Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 98 France Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 99 France Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 100 France Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 101 France Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 102 France Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 103 France Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 104 France Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 105 France Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 106 France Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 107 Italy Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 108 Italy Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 109 Italy Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 110 Italy Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 111 Italy Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 112 Italy Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 113 Italy Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 114 Italy Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 115 Italy Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 116 Italy Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 117 Italy Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 118 Italy Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 119 Italy Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 120 Italy Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 121 Italy Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 122 Spain Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 123 Spain Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 124 Spain Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 125 Spain Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 126 Spain Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 127 Spain Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 128 Spain Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 129 Spain Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 130 Spain Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 131 Spain Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 132 Spain Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 133 Spain Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 134 Spain Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 135 Spain Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 136 Spain Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 137 Netherlands Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 138 Netherlands Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 139 Netherlands Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 140 Netherlands Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 141 Netherlands Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 142 Netherlands Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 143 Netherlands Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 144 Netherlands Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 145 Netherlands Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 146 Netherlands Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 147 Netherlands Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 148 Netherlands Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 149 Netherlands Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 150 Netherlands Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 151 Netherlands Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 152 Switzerland Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 153 Switzerland Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 154 Switzerland Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 155 Switzerland Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 156 Switzerland Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 157 Switzerland Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 158 Switzerland Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 159 Switzerland Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 160 Switzerland Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 161 Switzerland Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 162 Switzerland Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 163 Switzerland Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 164 Switzerland Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 165 Switzerland Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 166 Switzerland Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 167 Russia Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 168 Russia Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 169 Russia Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 170 Russia Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 171 Russia Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 172 Russia Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 173 Russia Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 174 Russia Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 175 Russia Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 176 Russia Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 177 Russia Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 178 Russia Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 179 Russia Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 180 Russia Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 181 Russia Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 182 TURKEY Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 183 TURKEY Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 184 TURKEY Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 185 TURKEY Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 186 TURKEY Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 187 TURKEY Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 188 TURKEY Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 189 TURKEY Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 190 TURKEY Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 191 TURKEY Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 192 TURKEY Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 193 TURKEY Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 194 TURKEY Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 195 TURKEY Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 196 TURKEY Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 197 Rest of Europe Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

Lista de Figura

FIGURE 1 Europe LENTIVIRAL VECTOR MARKET: SEGMENTATION

FIGURE 2 EUROPE LENTIVIRAL VECTOR MARKET: DATA TRIANGULATION

FIGURE 3 Europe Lentiviral vector market: DROC ANALYSIS

FIGURE 4 Europe Lentiviral vector market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Lentiviral vector market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Lentiviral vector market: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Lentiviral vector market: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE LENTIVIRAL VECTOR MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE LENTIVIRAL VECTOR MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE lentiviral vector market: MARKET application COVERAGE GRID

FIGURE 11 Europe Lentiviral vector market: SEGMENTATION

FIGURE 12 growing geriatric population is expected to DRIVe THE Europe Lentiviral vector market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 lentivirus packaging systems SEGMENT is expected to account for the largest share of the Europe LENTIVIRAL VECTOR MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF Europe lentiviral vector market

FIGURE 15 Europe lentiviral vector market: By component, 2020

FIGURE 16 Europe lentiviral vector market: By component, 2019-2028 (USD million)

FIGURE 17 Europe lentiviral vector market: By component, CAGR (2021-2028)

FIGURE 18 Europe lentiviral vector market: By component, LIFELINE CURVE

FIGURE 19 Europe lentiviral vector market: By TYPE, 2020

FIGURE 20 Europe lentiviral vector market: By TYPE, 2019-2028 (USD million)

FIGURE 21 Europe lentiviral vector market: By TYPE, CAGR (2021-2028)

FIGURE 22 Europe lentiviral vector market: By TYPE, LIFELINE CURVE

FIGURE 23 Europe lentiviral vector market: By generation, 2020

FIGURE 24 Europe lentiviral vector market: By generation, 2019-2028 (USD million)

FIGURE 25 Europe lentiviral vector market: By generation, CAGR (2021-2028)

FIGURE 26 Europe lentiviral vector market: By generation, LIFELINE CURVE

FIGURE 27 Europe lentiviral vector market: By work flow, 2020

FIGURE 28 Europe lentiviral vector market: By work flow, 2019-2028 (USD million)

FIGURE 29 Europe lentiviral vector market: By work flow, CAGR (2021-2028)

FIGURE 30 Europe lentiviral vector market: By work flow, LIFELINE CURVE

FIGURE 31 Europe lentiviral vector market: By delivery method, 2020

FIGURE 32 Europe lentiviral vector market: By delivery method, 2019-2028 (USD million)

FIGURE 33 Europe lentiviral vector market: By delivery method, CAGR (2021-2028)

FIGURE 34 Europe lentiviral vector market: By delivery method, LIFELINE CURVE

FIGURE 35 Europe lentiviral vector market: By disease indication, 2020

FIGURE 36 Europe lentiviral vector market: By disease indication, 2019-2028 (USD million)

FIGURE 37 Europe lentiviral vector market: By disease indication, CAGR (2021-2028)

FIGURE 38 Europe lentiviral vector market: By disease indication, LIFELINE CURVE

FIGURE 39 Europe lentiviral vector market: By application, 2020

FIGURE 40 Europe lentiviral vector market: By application, 2019-2028 (USD million)

FIGURE 41 Europe lentiviral vector market: By application, CAGR (2021-2028)

FIGURE 42 Europe lentiviral vector market: By application, LIFELINE CURVE

FIGURE 43 Europe lentiviral vector market: By end user, 2020

FIGURE 44 Europe lentiviral vector market: By end user, 2019-2028 (USD million)

FIGURE 45 Europe lentiviral vector market: By end user, CAGR (2021-2028)

FIGURE 46 Europe lentiviral vector market: By end user, LIFELINE CURVE

FIGURE 47 EUROPE Lentiviral Vector MARKET: SNAPSHOT (2020)

FIGURE 48 EUROPE Lentiviral Vector MARKET: BY COUNTRY (2020)

FIGURE 49 EUROPE Lentiviral Vector MARKET: BY COUNTRY (2021 & 2028)

FIGURE 50 EUROPE Lentiviral Vector MARKET: BY COUNTRY (2020 & 2028)

FIGURE 51 EUROPE Lentiviral Vector MARKET: BY COMPONENT (2021-2028)

FIGURE 52 Europe Lentiviral Vector Market: company share 2020 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Navegue pelas páginas relacionadas

Banner